Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Terminated

• Conditions: Brain Cancer; Prostate Cancer; Lung Cancer

• Registration Number: NCT01987193
• Lead Sponsor: University of Florida

Brief Summary

The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2012-07
• Study First Submitted: 2013-10-24
• Study First Submitted QC: 2013-11-12
• Study First Posted: 2013-11-19
• Status Verified: 2018-05
• Primary Completion: 2018-05
• Study Completion: 2018-05
• Last Update Submitted: 2018-05-24
• Last Update Posted: 2018-05-29

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

Solid tumors in the intracranial, thoracic, or pelvic regions.

Read More

Exclusion Criteria

N/A

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients with hypoxic tumor identified by tumor blood flow measurement.	3 months

Trial Locations

Locations (1)

University of Florida Proton Therapy Institute; 🇺🇸 Jacksonville, Florida, United States